Discovery & Development
What makes us unique?
CRT offers both discovery and early clinical development capability.
Find out more ›
Scientists & Inventors
Do you have an idea?
CRT has more than 20 years experience in developing and commercialising technology.
Find out more ›
Institutes & Charities
Looking for a partner?
Personalised services to reflect your requirements and progress your research.
Find out more ›
Research Tools
For further information about antibodies, mouse models and cell lines from CRT or to discuss sales or licensing options, please contact us:
Call +44 (0) 20 3469 6300 Email reagents@cancertechnology.com Please read our disclaimer information View Research toolsSubscribe to our newsletter
Licensing Portfolio
Cancer Research Technology has an impressive range of over 200 oncology-focused projects under development and potentially available for licensing.
Search Licensing Portfolio
Featured Opportunities
News
CRT and The EIF unveil innovative £50M cancer fund to bridge ‘development gap’ in UK
CRT and the European Investment Fund (EIF) have joined together to create a £50M investment fund to bridge the funding gap in the UK between cancer drug discovery and early development. Read more ›